Compound Summary
Compound Information
ethoxzolamide
Compound Name: | ethoxzolamide |
Compound CID: | 3295 |
Synonyms: | ethoxzolamide Ethoxyzolamide 452-35-7 Ethoxazolamide 6-Ethoxy-2-benzothiazolesulfonamide More... |
Iupac Name: | 6-ethoxy-1,3-benzothiazole-2-sulfonamide |
InChI: | InChI=1S/C9H10N2O3S2/c1-2-14-6-3-4-7-8(5-6)15-9(11-7)16(10,12)13/h3-5H,2H2,1H3,(H2,10,12,13) |
InChIKey: | OUZWUKMCLIBBOG-UHFFFAOYSA-N |
Canonical Smiles: | CCOC1=CC2=C(C=C1)N=C(S2)S(=O)(=O)N |
Isomeric Smiles: | CCOC1=CC2=C(C=C1)N=C(S2)S(=O)(=O)N |
Molecular Weight: | 258.3 |
Molecular Formula: | C9H10N2O3S2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
ethoxzolamide
Molecular Weight: | 258.3 |
Molecular Formula: | C9H10N2O3S2 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 6 |
Rotatable Bond Count: | 3 |
Heavy Atom Count: | 16 |
Complexity: | 341 |
Synonyms
ethoxzolamide
| ethoxzolamide | ethoxzolamide |
|---|---|
ethoxzolamide |
Ethoxyzolamide |
452-35-7 |
Ethoxazolamide |
6-Ethoxy-2-benzothiazolesulfonamide |
Ethamide |
Etoxzolamide |
Cardrase |
6-Ethoxy-1,3-benzothiazole-2-sulfonamide |
Glaucotensil |
Diuretic C |
Redupresin |
2-Benzothiazolesulfonamide, 6-ethoxy- |
6-Ethoxybenzodthiazole-2-sulfonamide |
6-Ethoxybenzothiazole-2-sulfonamide |
6-Ethoxyzolamide |
6-Ethoxybenzothiazole-2-sulphonamide |
U-4191 |
NSC 10679 |
UNII-Z52H4811WX |
CHEMBL18 |
Redupresin;L-643786;PNU-4191 |
MLS000028637 |
6-Ethoxy-benzothiazole-2-sulfonic acid amide |
Mingoral |
CHEBI:101096 |
Z52H4811WX |
6-Ethoxy-2-benzothiazole8ulfonamide |
MFCD00057089 |
NCGC00018249-04 |
SMR000059148 |
DSSTox_CID_3021 |
DSSTox_RID_76834 |
DSSTox_GSID_23021 |
C9H10N2O3S2 |
Cardrase (TN) |
CAS-452-35-7 |
EZL |
Ethoxzolamide USP |
HSDB 3268 |
EINECS 207-199-5 |
BRN 0212240 |
Athamid |
AI3-50805 |
3caj |
3dcw |
3mdz |
Ethoxzolamide, EZM |
3dd0 |
Opera_ID_1207 |
6-(ethyloxy)-1,3-benzothiazole-2-sulfonamide |
SCHEMBL63941 |
4-27-00-04404 (Beilstein Handbook Reference) |
MLS001077357 |
GTPL6814 |
DTXSID1023021 |
BDBM10882 |
ZINC56721 |
HMS2093J03 |
HMS2094M03 |
HMS2233N09 |
HMS3373K15 |
HMS3715F20 |
HMS3746M15 |
Pharmakon1600-01505426 |
BCP24088 |
HY-B1480 |
NSC10679 |
PNU-4191 |
Tox21_110848 |
2179AH |
6-ethoxy-2-benzothiazole sulfonamide |
NSC-10679 |
NSC759129 |
WLN: T56 BN DSJ CSZW GO2 |
AKOS015915628 |
Tox21_110848_1 |
CCG-213432 |
CS-7836 |
DB00311 |
MCULE-3766215049 |
NSC-759129 |
VS-0126 |
Benzothiazole, 6-ethoxy-2-sulfonamide- |
NCGC00018249-01 |
NCGC00018249-02 |
NCGC00018249-03 |
NCGC00018249-05 |
NCGC00022533-04 |
NCGC00186657-01 |
ST086115 |
6-Ethoxy-2-benzothiazolesulfonamide, 97% |
SBI-0206851.P001 |
6-Ethoxy-1,3-benzothiazole-2-sulfonamide # |
FT-0707866 |
ST51007023 |
SW220095-1 |
D02441 |
AB00383049_12 |
AB00383049_13 |
Q265352 |
SR-01000000236 |
L-643786 |
SR-01000000236-2 |
BRD-K18131774-001-10-1 |
Ethoxzolamide, United States Pharmacopeia (USP) Reference Standard |
Experimental Data
ethoxzolamide
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drosophila melanogaster | 200 | umol/L | 43.17 | 46.27 | 7.194 | NS | MALES | 33008901 | Inactive | ||||
| Drosophila melanogaster | 20 | umol/L | 44.63 | 46.93 | 5.151 | NS | FEMALES | 33008901 | Inactive | ||||
| Caenorhabditis elegans | 100 | umol/L | 17.25 | 16.88 | -2.162 | NS | N2 | 33008901 | Inactive | ||||
| Caenorhabditis elegans | 10 | umol/L | 16.6 | 16.09 | -3.093 | NS | N2 | 33008901 | Inactive |
Experimental Data Visualization
ethoxzolamide
Statistics Data
ethoxzolamide
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -2.162 | 1 | 2 | |
| Drosophila melanogaster | 7.194 | 1 | 2 |
Statistics Data Visualization
ethoxzolamide
